1. Market Research
  2. > Business Services
  3. > Business Outsourcing Market Trends
  4. > Adaptive Trials: Market Dynamics and Service Provider Benchmarking

Adaptive Trials: Market Dynamics and Service Provider Benchmarking

  • February 2015
  • -
  • Industry Standard Research
  • -
  • 92 pages

Report Overview

This report offers sponsors, CROs, and specialist adaptive trial companies an in-depth look at the market dynamics, perception, and use of adaptive trials as they are quickly becoming a fundamental piece of the clinical development process. ISR has dedicated a section of this report to provider perceptions and user experiences. This section examines how more than 25 adaptive trial service providers are perceived and perform relative to the expectations of sponsors. These results not only give sponsors an inside look at who is who in the adaptive trial space, but also give CROs and specialist adaptive trial companies an idea of how they stack up against their peers.

What you will learn in this report:

- Current and projected use of adaptive trial designs
- Relative length and cost of adaptive trials
- Reasons for conducting adaptive trials and barriers to adoption
- Therapeutic areas best suited for adaptive trial designs
- Adaptive trial service provider performance and leaders

How you can use this report:

Identify trends in adaptive trial conduct and outsourcing (i.e. drivers and barriers, outsourcing trial design vs. clinical operations, levels of adoption, etc.)
- Set realistic goals by understanding adaptive trial timing and costs
- Service Providers: Benchmark your adaptive trial offering and use these data to inform your sales and marketing efforts surrounding adaptive trials
- Learn about the future of adaptive trial design and outsourcing

Table Of Contents

Adaptive Trials: Market Dynamics and Service Provider Benchmarking
Copyright and Usage Guidelines 5
Methodology 6
Introduction 7
Executive Summary 9
Use of Adaptive Trial Designs 13
Current Use 14
Projected Use 14
Use of Adaptive Trials by Phase 15
Reasons for Conducting Adaptive Trials 16
Perceived Riskiness of Adaptive Design 17
Adaptive Trials Relative to Non-adaptive Trials 18
Relative Length of Adaptive Trials 19
Relative Cost of Adaptive Trials 20
Perceptions of Adaptive Designs 21
Best Reasons for Conducting Adaptive Trials 22
Momentum of Adaptive Trial Design 23
Reasons for Increased Momentum in Adaptive Trial Design 24
Reasons for Decreased Momentum in Adaptive Trial Design 25
Barriers to Adaptive Trial Adoption 26
Importance of Change Management 28
Connection between Adaptive Trials and Biomarkers and Personalized Medicine 29
Implementation of Adaptive Trials 30
Use of Adaptive Trial Design Task Force 31
Current and Projected Types of Adaptive Trials Utilized 32
Therapeutic Areas Utilizing Adaptive Trials 33
Therapeutic Areas Best Suited for Adaptive Designs 34
Aspects of a Trial Most Impacted by the Adaptive Design 35
Outsourcing Behaviors and Preferences 36
Comfort in Outsourcing Aspects of Adaptive Trials 37
Outsourcing of Specific Trial Components 38
Importance of Study Design and Execution Capabilities 40
Important Attributes Considered When Selecting a Service Provider 41
Importance of Particular Trial Operations Capabilities 42
Provider Perception and User Experience 43
Awareness of Adaptive Trial Service Providers 44
Leaders in Adaptive Trial Services 45
Adaptive Trial Service Providers Sending Proposals 46
Use of Adaptive Trial Service Providers 47
Service Provider Activity Summary Table 48
Provider Performance against Expectations for Adaptive Trial Design 49
Adaptive Trial Provider Usage for Clinical Operations 50
Provider Performance against Expectations for Clinical Operations 51
Adaptive Design Software Packages Used for Trial Design 52
Study Data 53
Use of Adaptive Trial Design 54
Current Use 54
Projected Use 54
Use of Adaptive Trial by Phase 55
Reason for Conducting Adaptive Trials 56
Riskiness of Adaptive Design 56
Adaptive Trials Relative to Non-adaptive Trials 57
Relative Length of Adaptive Trials 57
Relative Cost of Adaptive Trials 57
Perception of Adaptive Designs 58
Main Reasons for Conducting Adaptive Trials 58
Momentum of Adaptive Trial Design 59
Reasons for Increased Momentum in Adaptive Trial Design 60
Reasons for Decreased Momentum in Adaptive Trial Design 60
Reason for No Change in Momentum of Adaptive Trial Designs (Verbatim) 61
Barriers to Adaptive Trial Adoption 62
Importance of Change Management 64
Likelihood to Pay a Service Provider to Assist with Change Management 64
Connection between Adaptive Trials and Biomarkers 65
Connection between Adaptive Trials and Personalized Medicine 65
Implementation and Handling of Adaptive Trials 66
Use of Adaptive Trial Design Task Force 66
Awareness of Clinical Operations Technologies designed for Adaptive Trials 66
Current and Projected Types of Adaptive Trials Utilized 67
Type of Adaptive Trial Receiving the Most Attention (Next 5 Years) 68
Therapeutic Areas Utilizing Adaptive Trials 69
Therapeutic Areas Best Suited for Adaptive Designs 70
Aspects of a Trial Most Impacted by the Adaptive Design 71
Validation of Adaptive Trial Software 72
Importance of Adaptive Trial Validation 72
Adaptive Design Software Packages Used for Trial Design 73
Outsourcing Behavior and Preferences 74
Comfort in Outsourcing Aspects of Adaptive Trials 74
Importance of Adaptive Design and Execution Capabilities 75
Important Attributes Considered When Selecting a Service Provider 76
Importance of Particular Capabilities 77
In-house vs Outsourced Statistical Program 77
Validation of Adaptive Trial Design Software 78
Provider Perception and User Experience 79
Awareness of Adaptive Trial Service Providers 79
Leaders in Adaptive Trial Services 80
Adaptive Trial Service Providers Sending Proposals 81
Use of Adaptive Trial Service Providers 82
Provider Performance against Expectations for Study Design 83
Provider Performance Against Expectations for Clinical Operations 85
Demographics 86
Type of Company 86
Decision-Making Responsibility 87
Clinical Development Process Familiarity 88
Phase Responsibility 89
Job Title 89
Headquarters/Office Location 90
Involvement with Adaptive Clinical Trials 91
In-house vs Outsourced Clinical Development Activities 91
About Industry Standard Research 92

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Data Center as a Bottleneck: Market Strategies, Analysis and Opportunities

Data Center as a Bottleneck: Market Strategies, Analysis and Opportunities

  • $ 19000
  • Industry report
  • January 2017
  • by WinterGreen Research

This 2017 module has 138 pages and 67 tables and figures Worldwide hyperscale data center markets implement cloud computing with shared resource and the aim, more or less achieved of providing foolproof ...

Asia-Pacific Network-based Advanced Malware Analysis (NAMA) Solutions Market

Asia-Pacific Network-based Advanced Malware Analysis (NAMA) Solutions Market

  • $ 15000
  • Industry report
  • December 2016
  • by Frost & Sullivan

The Need to Defend Against Zero-day and Ransomware Attacks Driving the Adoption of NAMA Solutions The network-based advanced malware analysis solutions market in Asia-Pacific (APAC) continued to maintain ...

Network orchestration and management systems: worldwide forecast 2016–2020

Network orchestration and management systems: worldwide forecast 2016–2020

  • $ 7999
  • Industry report
  • December 2016
  • by Analysys Mason

"Communications service providers should not go too far down the network virtualisation path without implementing a network orchestration strategy." Spending on traditional network management systems (NMS) ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.